Vaccinia-based oncolytic immunotherapy Pexastimogene...

OncoImmunology 2019 / 08 Vol. 8; Iss. 8

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Haberset
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2019.1615817
Date:
August, 2019
File:
PDF, 3.03 MB
english, 2019
Conversion to is in progress
Conversion to is failed